动脉瘤性蛛网膜下腔出血患者不可逆全脑功能丧失与器官捐献
回顾性分析2011年1月至2016年12月一所大学医学中心治疗的395例动脉瘤性蛛网膜下腔出血患者,评估不可逆全脑功能丧失(脑死亡)后器官捐献的患病率与临床特征。入院后18.0%(n=71)患者死亡,其中50.7%(n=36)诊断为不可逆全脑功能丧失,32.4%(n=23)成为器官捐献者,男性捐献显著多于女性(P=0.008)。
要点
- 395例aSAH患者入院后18.0%(n=71)死亡,死亡者中50.7%(n=36)诊断为不可逆全脑功能丧失。
- 不可逆全脑功能丧失患者中32.4%(n=23)成为器官捐献者,男性显著多于女性(P=0.008)。
- 共获取85个器官用于捐献,包括42个肾脏、21个肝脏、3个胰腺、11个心脏和8个肺。
核心结论
- 在致死性动脉瘤性蛛网膜下腔出血背景下,不可逆全脑功能丧失是常见诊断,对神经重症监护医生提出复杂要求。
- 作者展示了动脉瘤性蛛网膜下腔出血患者转为器官捐献者的临床特征和流行病学因素。
研究设计与样本
- 回顾性分析一所大学医学中心2011年1月至2016年12月治疗的395例动脉瘤性蛛网膜下腔出血患者的匿名临床数据集。
- 评估器官捐献同意率及临床特征,包括诊断不可逆全脑功能丧失的参数。
主要发现
- 入院重症监护病房后18.0%的患者(n=71)死亡(格拉斯哥结局量表评分1)。
- 死亡患者中脑内出血占42.3%,动脉瘤再出血占19.7%,脑室内出血占87.3%。
- 死亡患者中50.7%(n=36)诊断为不可逆全脑功能丧失,其中32.4%(n=23)成为器官捐献者。
- 55.6%的患者进行了额外诊断性脑电图检查。
- 男性患者成为器官捐献者显著多于女性患者(P=0.008);不可逆全脑功能丧失并后续器官捐献主要见于60岁以下患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening disease with an often fatal clinical course leading to irreversible loss of brain function (ILBF) (i.e., brain death). The purpose of this study was to assess the prevalence and characteristics of patients with aSAH who became organ donors after diagnosis of ILBF. METHODS: Anonymized clinical data sets of 395 patients treated for aSAH at a university medical center from January 2011 to December 2016 were retrospectively analyzed. Prevalence of consent for organ donation and clinical characteristics, including parameters for diagnosis of irreversible loss of brain function, were assessed. RESULTS: After initial admission to the intensive care unit, 18.0% of patients (n = 71) died (Glasgow Outcome Scale score 1). Intracerebral hemorrhage occurred in 42.3% of patients who died, aneurysmal rebleeding occurred in 19.7%, and intraventricular hemorrhage occurred in 87.3%. In 50.7% of patients who died (n = 36), ILBF was diagnosed, and 32.4% (n = 23) of these patients became organ donors. In 55.6%, additional diagnostic electroencephalography was performed. Male patients significantly more often became organ donors than female patients (P = 0.008). ILBF with subsequent organ donation was predominantly seen in patients <60 years old. A total 85 of organs were explanted for donation, including 42 kidneys, 21 livers, 3 pancreas, 11 hearts and 8 lungs. CONCLUSIONS: ILBF in the setting of fatal aSAH is a prevalent diagnosis with complex demands for neurointensive care physicians. We demonstrated the clinical characteristics and epidemiologic factors of patients with aSAH converting to organ donors.
引用
- Mohme M, Sauvigny T, Grensemann J, et al. Irreversible Total Loss of Brain Function and Organ Donation in Patients with Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2017. PMID: 28619501. doi:10.1016/j.wneu.2017.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。